Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.370.360.340.320.33

What is the latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS is 0.37 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.37
Mar20240.36
Mar20230.34
Mar20220.32
Mar20210.33

How is Fixed Capital/Sales of LINCOLN PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.37
2.78
Mar2024 0.36
5.88
Mar2023 0.34
6.25
Mar2022 0.32
-3.03
Mar2021 0.33 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,057.6 Cr 13% 8.5% -28.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

13%

8.5%

-28.8%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses